USD10
OVID Shares
About Ovid TherapeuticsOvid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
USD10
OVID Shares
About Ovid TherapeuticsOvid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Stats
TRADING WINDOW
Closed
OPENS AT
Sep 28 at 1:30 PM UTC
MARKET CAP
$480.43M
OPEN PRICE
$2.40
LOW (1Y)
$1.18
HIGH (1Y)
$3.11
LOW (24H)
$2.35
HIGH (24H)
$2.49
VOLUME (24H)
$1.19M
12.64%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.40 | |
1 Day | $2.35 | |
1 Week | $2.78 | |
1 Month | $2.74 | |
1 Year | $1.40 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.